Clinical Trials Browser

Phase 2 × Biosimilar Pharmaceuticals × 90 days × Clear all

NCT07220135 2026-05-06

NeoTHERa

Phase 2 Recruiting

Breast Neoplasms

NCT06649331 2026-04-08

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms